| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $279.1M | +4.6% |
| R&D Expense | $45.5M | +2.9% |
| SG&A Expense | $45.7M | +3.6% |
| Operating Income | $16.0M | +28.7% |
| Pre-tax Income | $18.5M | +18.8% |
| Income Tax | $3.3M | -5.6% |
| Net Income | $15.2M | +25.8% |
| EPS (Basic) | $0.50 | +28.2% |
| EPS (Diluted) | $0.50 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.3M | -12.4% |
| Accounts Receivable | $34.3M | -6.5% |
| Current Assets | $130.2M | +13.8% |
| Total Assets | $499.9M | +0.4% |
| Current Liabilities | $118.4M | +1.0% |
| Stockholders' Equity | $340.8M | +2.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $64.0M | +25.0% |
| Capital Expenditures | $2.2M | +24.4% |
| Investing Cash Flow | -$56.6M | -99.4% |
| Financing Cash Flow | -$13.0M | +45.0% |
| Free Cash Flow | $61.8M | +25.0% |
| +28.2% |